Now livetag icon
Digital 100 - Similarweb official ranking of the fastest growing digital brandsMeet the leading brands of 2026banner icon

Analyse de l'application OzemPro: GLP1 Tracker pour le 31 janvier

OzemPro: GLP1 Tracker

OzemPro: GLP1 Tracker

  • FITCAL LTDA
  • App Store Apple
  • Gratuit
  • Santé & Fitness
OzemPro is a GLP-1 tracker app designed to help people using GLP-1 medications track injections, symptoms, weight, and daily habits in a simple, structured way. Whether you’re using Ozempic®, Wegovy®, Mounjaro®, Zepbound®, semaglutide, tirzepatide, or other GLP-1 medications, OzemPro works as a dedicated GLP-1 tracker to organize your treatment routine and progress in one place. A complete GLP-1 tracker for your routine GLP-1 treatments often require consistent tracking — weekly injections, symptom changes, side effects, weight fluctuations, and lifestyle habits. OzemPro was built specifically as a GLP-1 tracker app to support this process without complexity. Instead of using multiple apps, OzemPro brings everything together into one Ozempic tracker and GLP-1 monitoring app, helping you stay consistent and informed over time. Key features of the GLP-1 tracker app • GLP-1 injection tracker Track weekly injection days for Ozempic, Mounjaro, Wegovy, Zepbound, semaglutide, and tirzepatide. • Ozempic & Mounjaro symptom tracking Log side effects and symptoms associated with GLP-1 medications to better understand how your body responds. • Weight and progress tracking Monitor weight trends, body measurements, and lifestyle data with clear weekly charts. • Daily health tracking Track protein, fiber intake, water consumption, steps, weight, and injection history in one organized GLP-1 tracker. • Injection reminders Personalized notifications help you stay consistent with your weekly GLP-1 injections. • Journey timeline Save progress photos, measurements, and milestones to visualize your GLP-1 journey. • Home Screen widget Stay engaged with a motivational widget that keeps your GLP-1 tracking visible throughout the day. • Smart food logging Estimate protein and fiber automatically using photo recognition or barcode scanning. • Apple Health integration Sync activity and movement data from Apple Health for a complete overview. • Organized insights Review injections, symptoms, weight changes, and habits through clean timelines and charts. Important notice OzemPro is a tracking and educational support app. It does not provide medical advice, diagnosis, or treatment. Always follow guidance from your healthcare provider when using GLP-1 medications such as Ozempic, semaglutide, tirzepatide, or Mounjaro. Non-affiliation notice OzemPro is an independent application and is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any pharmaceutical manufacturer. All trademarks belong to their respective owners and are mentioned only for compatibility and informational purposes. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
OzemPro: GLP1 Tracker

Classement dans le store

Le classement des stores est basé sur plusieurs paramètres définis par Google et Apple.

Toutes les catégories dans
États-Unis--
Santé & Fitness dans
États-Unis--
Créez un compte pour voir les téléchargements mensuels moyensContactez-nous

Statistiques de classement dans le temps pour OzemPro: GLP1 Tracker

Classement d'utilisation et classement Apple App Store de Similarweb pour OzemPro: GLP1 Tracker

Classement

Aucune donnée disponible

Ranking par pays pour OzemPro: GLP1 Tracker

Pays dans lesquels OzemPro: GLP1 Tracker est le mieux classé dans ses principales catégories


Principaux concurrents & apps alternatives

Applications ayant une forte probabilité d'être utilisées par les mêmes utilisateurs, à partir du même store.

Ozempic Tracker

Ozempic Tracker

Pode Co, LLC

Shotsy - GLP-1 Tracker

Shotsy - GLP-1 Tracker

Shotsy Co.

ShotFit: GLP-1 Tracker

ShotFit: GLP-1 Tracker

Serhat Bugra Turkmen

Weight loss tracker - BMI

Weight loss tracker - BMI

Aurel Criste

OzemPro: GLP1 Tracker VS.

janvier 31, 2026